Allergan (AGN -3.5%) dips after its Q3 swung to a profit on strong specialty pharmaceutical...

|About: Allergan plc (AGN)|By:, SA News Editor

Allergan (AGN -3.5%) dips after its Q3 swung to a profit on strong specialty pharmaceutical sales, but the company's issues cautious Q4 guidance below Street estimates. It now forecasts current-quarter earnings of between $0.97 - $0.99 per share on sales of $1.33B to $1.41B, below analysts expectations for an EPS of $1.01 on revenue of $1.41B.